HMGA2 and colorectal cancer: However, S100A4 knockdown did not exhibit higher cytotoxicity in DLD-1-HMGA2 cells as niclosamide did (Figure 8E), confirming that S100A4 downregulation was not sufficient to selectively kill HMGA2-overexpressing colorectal cancer cells.